A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.
Shapiro
R
R
Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Scantlebury
V P
VP
Jordan
M L
ML
Vivas
C A
CA
Jain
A
A
Hakala
T R
TR
McCauley
J
J
Johnston
J
J
Randhawa
P
P
Fedorek
S
S
Gray
E
E
Chesky
A
A
Dvorchik
I
I
Donaldson
J
J
Fung
J J
JJ
Starzl
T E
TE
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D010865:Pilot Projects; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology; D020123:Sirolimus / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D003404:Creatinine; D020123:Sirolimus; D016559:Tacrolimus